Mechanisms behind the non-thyroidal illness syndrome: An update

Journal of Endocrinology

Volumn 205, Issue 1, 2010, Pages 1-13

  Warner, Maria H ^a   Beckett, Geoffrey J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; HORMONE BINDING PROTEIN; IODIDE PEROXIDASE; IODOTHYRONINE DEIODINASE D2; IODOTHYRONINE DEIODINASE D3; LEPTIN; LIOTHYRONINE; PROTIRELIN; SELENIUM; THYROID HORMONE; THYROID HORMONE RECEPTOR; THYROTROPIN; THYROXINE; UNCLASSIFIED DRUG;

ACUTE DISEASE; CHRONIC DISEASE; COMPARATIVE STUDY; CONVALESCENCE; DEIODINATION; DIET RESTRICTION; DISEASE MODEL; HEALTH; HORMONE SYNTHESIS; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; HYPOTHYROIDISM; IN VIVO STUDY; INJURY; KIDNEY FAILURE; KNOCKOUT MOUSE; LIOTHYRONINE BLOOD LEVEL; LIVER FAILURE; MALNUTRITION; NON THYROIDAL ILLNESS SYNDROME; NONHUMAN; PLASMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; REVIEW; SEPSIS; THYROID DISEASE; THYROID FUNCTION TEST; THYROID HORMONE BLOOD LEVEL; THYROID HORMONE METABOLISM; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

ANIMALS; DISEASE MODELS, ANIMAL; EUTHYROID SICK SYNDROMES; HORMONE REPLACEMENT THERAPY; HUMANS; IODIDE PEROXIDASE; LEPTIN; MICE; MICE, KNOCKOUT; RECEPTORS, THYROID HORMONE; THYROID HORMONES; THYROTROPIN-RELEASING HORMONE;

EID: 77949511133     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1677/JOE-09-0412     Document Type: Review

References (112)

1. Adriaanse R, Romijn JA, Brabant G, Endert E & Wiersinga WM 1993 Pulsatile thyrotropin secretion in nonthyroidal illness. Journal of Clinical Endocrinology and Metabolism 77 1313-1317.
2. Afandi B, Schussler GC, Arafeh AH, Boutros A, Yap MG & Finkelstein A 2000 Selective consumption of thyroxine-binding globulin during cardiac bypass surgery. Metabolism 49 270-274.
3. Amma LL, Campos-Barros A, Wang Z, Vennstrom B & Forrest D 2001 Distinct tissue-specific roles for thyroid hormone receptors beta and alpha1 in regulation of type 1 deiodinase expression. Molecular Endocrinology 15 467-475.
4. Arem R & Cusi K 1997 Thyroid function testing in psychiatric illness: usefulness and limitations. Trends in Endocrinology and Metabolism 8 282-287.
5. Baqui MM, Gereben B, Harney JW, Larsen PR & Bianco AC 2000 Distinct subcellular localization of transiently expressed types 1 and 2 iodothyronine deiodinases as determined by immunofluorescence confocal microscopy. Endocrinology 141 4309-4312.
6. Bartalena L, Cossu E, Grasso L, Velluzzi F, Loviselli A, Cirillo R & Martino E 1993 Relationship between nocturnal serum thyrotropin peak and metabolic control in diabetic patients. Journal of Clinical Endocrinology and Metabolism 76 983-987.
7. Bartalena L, Bogazzi F, Brogioni S, Grasso L & Martino E 1998 Role of cytokines in the pathogenesis of the euthyroid sick syndrome. European Journal of Endocrinology 138 603-614.
8. Becker RA, Vaughan GM, Ziegler MG, Seraile LG, Goldfarb IW, Mansour EH, McManus WF, Pruitt BA Jr & Mason AD Jr 1982 Hypermetabolic low triiodothyronine syndrome of burn injury. Critical Care Medicine 10 870-875.
9. Beckett GJ 2006 Thyroid function and thyroid function tests in non-thyroidal illness. CPD Bulletin: Clinical Biochemistry 7 107-116.
10. Beckett GJ & Arthur JR 2005 Selenium and endocrine systems. Journal of Endocrinology 184 455-465.
11. Beckett GJ, Wilkinson E, Rae PW, Gow S, Wu PS & Toft AD 1991 The clinical utility of a non-isotopic two-step assay (DELFIA) and an analogue radioimmunoassay (SimulTRAC) for free thyroxine compared. Annals of Clinical Biochemistry 28 335-344.
12. Beigneux AP, Moser AH, Shigenaga JK, Grunfeld C & Feingold KR 2003 Sick euthyroid syndrome is associated with decreased TR expression and DNA binding in mouse liver. American Journal of Physiology. Endocrinology and Metabolism 284 E228-E236.
13. Bianco AC & Kim BW 2006 Deiodinases: implications of the local control of thyroid hormone action. Journal of Clinical Investigation 116 2571-2579.
14. Bianco AC, Salvatore D, Gereben B, Berry MJ & Larsen PR 2002 Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocrine Reviews 23 38-89.
15. Boelen A, Platvoet-Ter Schiphorst MC & Wiersinga WM 1993 Association between serum interleukin-6 and serum 3,5,3′-triiodothyronine in nonthyroidal illness. Journal of Clinical Endocrinology and Metabolism 77 1695-1699.
16. Boelen A, Platvoet-Ter Schiphorst MC & Wiersinga WM 1995 Soluble cytokine receptors and the low 3,5,3′-triiodothyronine syndrome in patients with nonthyroidal disease. Journal of Clinical Endocrinology and Metabolism 80 971-976.
17. Boelen A, Schiphorst MC & Wiersinga WM 1996 Relationship between serum 3,5,30-triiodothyronine and serum interleukin-8, interleukin-10 or interferon gamma in patients with nonthyroidal illness. Journal of Endocrinological Investigation 19 480-483.
18. Boelen A, Kwakkel J, Platvoet-ter Schiphorst M, Baur A, Kohrle J & Wiersinga WM 2004a Contribution of interleukin-12 to the pathogenesis of non-thyroidal illness. Hormone and Metabolic Research 36 101-106.
19. Boelen A, Kwakkel J, Thijssen-Timmer DC, Alkemade A, Fliers E & Wiersinga WM 2004b Simultaneous changes in central and peripheral components of the hypothalamus-pituitary-thyroid axis in lipopolysaccharide- induced acute illness in mice. Journal of Endocrinology 182 315-323.
20. Boelen A, Kwakkel J, Platvoet-ter Schiphorst M, Mentrup B, Baur A, Koehrle J & Wiersinga WM 2004c Interleukin-18, a proinflammatory cytokine, contributes to the pathogenesis of non-thyroidal illness mainly via the central part of the hypothalamus-pituitary-thyroid axis. European Journal of Endocrinology 151 497-502.
21. Boelen A, Kwakkel J, Alkemade A, Renckens R, Kaptein E, Kuiper G, Wiersinga WM& Visser TJ 2005 Induction of type 3 deiodinase activity in inflammatory cells of mice with chronic local inflammation. Endocrinology 146 5128-5134.
22. Boelen A, Kwakkel J, Wiersinga WM & Fliers E 2006 Chronic local inflammation in mice results in decreased TRH and type 3 deiodinase mRNA expression in the hypothalamic paraventricular nucleus independently of diminished food intake. Journal of Endocrinology 191 707-714.
23. Boelen A, Wiersinga WM & Fliers E 2008 Fasting-induced changes in the hypothalamus-pituitary-thyroid axis. Thyroid 18 123-129.
24. Boelen A, Kwakkel J, Wieland CW, St Germain DL, Fliers E & Hernandez A 2009 Impaired bacterial clearance in type 3 deiodinase-deficient mice infected with Streptococcus pneumoniae. Endocrinology 150 1984-1990.
25. Brent GA & Hershman JM 1986 Thyroxine therapy in patients with severe nonthyroidal illnesses and low serum thyroxine concentration. Journal of Clinical Endocrinology and Metabolism 63 1-8.
26. 3 in the rat. Journal of Clinical Investigation 91 2709-2713.
27. Chiamolera MI & Wondisford FE 2009 Minireview: thyrotropin-releasing hormone and the thyroid hormone feedback mechanism. Endocrinology 150 1091-1096.
28. Chopra IJ 1997 Clinical review 86: euthyroid sick syndrome: is it a misnomer? Journal of Clinical Endocrinology and Metabolism 82 329-334.
29. Christofides ND, Wilkinson E, Stoddart M, Ray DC & Beckett GJ 1999a Serum thyroxine binding capacity-dependent bias in an automated free thyroxine assay. Journal of Immunoassay 20 201-221.
30. Christofides ND, Wilkinson E, Stoddart M, Ray DC & Beckett GJ 1999b Assessment of serum thyroxine binding capacity-dependent biases in free thyroxine assays. Clinical Chemistry 45 520-525.
31. 3 and UCP2. Cell Metabolism 5 21-33.
32. Costante G, Sand G, Reding P & Glinoer D 1985 Absence of circulating desialylated thyroxine-binding globulin in patients with hepatobiliary disease. Acta Endocrinologica 108 392-400.
33. Davis PJ, Davis FB & Lin HY 2008 Promotion by thyroid hormone of cytoplasm-to-nucleus shuttling of thyroid hormone receptors. Steroids 73 1013-1017.
34. Dayan CM & Panicker V 2009 Novel insights into thyroid hormones from the study of common genetic variation. Nature Reviews. Endocrinology 5 211-218.
35. Debaveye Y, Ellger B, Mebis L, Darras VM & Van den Berghe G 2008 Regulation of tissue iodothyronine deiodinase activity in a model of prolonged critical illness. Thyroid 18 551-560.
36. De Groot LJ 2006 Non-thyroidal illness syndrome is a manifestation of hypothalamic-pituitary dysfunction, and in view of current evidence, should be treated with appropriate replacement therapies. Critical Care Clinics 22 57-86 (vi).
37. 4 methods in premature infants. Journal of Pediatrics 151 404-408.
38. Dickson PW, Howlett GJ & Schreiber G 1982 Metabolism of prealbumin in rats and changes induced by acute inflammation. European Journal of Biochemistry 129 289-293.
39. Dumitrescu AM, Liao XH, Weiss RE, Millen K & Refetoff S 2006 Tissue-specific thyroid hormone deprivation and excess in monocarboxylate transporter (mct) 8-deficient mice. Endocrinology 147 4036-4043.
40. 3) in non-thyroidal somatic illness, as measured by ultrafiltration and immunoextraction. Clinica Chimica Acta 256 115-123.
41. Faber J, Kirkegaard C, Rasmussen B, Westh H, Busch-Sorensen M & Jensen IW 1987 Pituitary-thyroid axis in critical illness. Journal of Clinical Endocrinology and Metabolism 65 315-320.
42. Farwell AP 2008 Thyroid hormone therapy is not indicated in the majority of patients with the sick euthyroid syndrome. Endocrine Practice 14 1180-1187.
43. Feingold K, Kim MS, Shigenaga J, Moser A & Grunfeld C 2004 Altered expression of nuclear hormone receptors and coactivators in mouse heart during the acute-phase response. American Journal of Physiology. Endocrinology and Metabolism 286 E201-E207.
44. Fekete C & Lechan RM 2007 Negative feedback regulation of hypophysiotropic thyrotropin-releasing hormone (TRH) synthesizing neurons: role of neuronal afferents and type 2 deiodinase. Frontiers in Neuroendocrinology 28 97-114.
45. Fekete C, Gereben B, Doleschall M, Harney JW, Dora JM, Bianco AC, Sarkar S, Liposits Z, Rand W, Emerson C et al. 2004 Lipopolysaccharide induces type 2 iodothyronine deiodinase in the mediobasal hypothalamus: implications for the nonthyroidal illness syndrome. Endocrinology 145 1649-1655.
46. Fekete C, Singru PS, Sarkar S, Rand WM & Lechan RM 2005 Ascending brainstem pathways are not involved in lipopolysaccharide-induced suppression of thyrotropin-releasing hormone gene expression in the hypothalamic paraventricular nucleus. Endocrinology 146 1357-1363.
47. Fliers E, Guldenaar SE, Wiersinga WM & Swaab DF 1997 Decreased hypothalamic thyrotropin-releasing hormone gene expression in patients with nonthyroidal illness. Journal of Clinical Endocrinology and Metabolism 82 4032-4036.
48. Fliers E, Alkemade A & Wiersinga WM 2001 The hypothalamic-pituitary- thyroid axis in critical illness. Best Practice and Research. Clinical Endocrinology and Metabolism 15 453-464.
49. Fliers E, Alkemade A, Wiersinga WM & Swaab DF 2006 Hypothalamic thyroid hormone feedback in health and disease. Progress in Brain Research 153 189-207.
50. Friesema EC, Kuiper GG, Jansen J, Visser TJ & Kester MH 2006 Thyroid hormone transport by the human monocarboxylate transporter 8 and its rate-limiting role in intracellular metabolism. Molecular Endocrinology 20 2761-2772.
51. 4 results attributable to thyroxine-binding proteins in serum dialysates and ultrafiltrates. Clinical Chemistry 53 985-988.
52. Fritz KS,Weiss RM, Nelson JC &Wilcox RB 2007b Unequal concentrations of free T3 and free T4 after ultrafiltration. Clinical Chemistry 53 1384-1385.
53. Galton VA, Schneider MJ, Clark AS & St Germain DL 2009 Life without thyroxine to 3,5,3′-triiodothyronine conversion: studies in mice devoid of the 50-deiodinases. Endocrinology 150 2957-2963.
54. Gardner DF, Carithers RL Jr & Utiger RD 1982 Thyroid function tests in patients with acute and resolved hepatitis B virus infection. Annals of Internal Medicine 96 450-452.
55. Gartner R 2009 Selenium and thyroid hormone axis in critical ill states: an overview of conflicting view points. Journal of Trace Elements in Medicine and Biology 23 71-74.
56. Geffner DL, Azukizawa M & Hershman JM 1975 Propylthiouracil blocks extrathyroidal conversion of thyroxine to triiodothyronine and augments thyrotropin secretion in man. Journal of Clinical Investigation 55 224-229.
57. Gereben B, Zeold A, Dentice M, Salvatore D & Bianco AC 2008a Activation and inactivation of thyroid hormone by deiodinases: local action with general consequences. Cellular and Molecular Life Sciences 65 570-590.
58. Gereben B, Zavacki AM, Ribich S, Kim BW, Huang SA, Simonides WS, Zeold A & Bianco AC 2008b Cellular and molecular basis of deiodinaseregulated thyroid hormone signaling. Endocrine Reviews 29 898-938.
59. Hamblin PS, Dyer SA, Mohr VS, Le Grand BA, Lim CF, Tuxen DV, Topliss DJ & Stockigt JR 1986 Relationship between thyrotropin and thyroxine changes during recovery from severe hypothyroxinemia of critical illness. Journal of Clinical Endocrinology and Metabolism 62 717-722.
60. Heemstra KA, Soeters MR, Fliers E, Serlie MJ, Burggraaf J, van Doorn MB, van der Klaauw AA, Romijn JA, Smit JW, Corssmit EP et al. 2009 Type 2 iodothyronine deiodinase in skeletal muscle: effects of hypothyroidism and fasting. Journal of Clinical Endocrinology and Metabolism 94 2144-2150.
61. Hein MD & Jackson IM 1990 Review: thyroid function in psychiatric illness. General Hospital Psychiatry 12 232-244.
62. Hennemann G, Docter R, Friesema EC, de Jong M, Krenning EP & Visser TJ 2001 Plasma membrane transport of thyroid hormones and its role in thyroid hormone metabolism and bioavailability. Endocrine Reviews 22 451-476.
63. 3 syndrome. American Journal of Physiology 251 E156-E163.
64. Hosoi Y, Murakami M, Mizuma H, Ogiwara T, Imamura M & Mori M 1999 Expression and regulation of type II iodothyronine deiodinase in cultured human skeletal muscle cells. Journal of Clinical Endocrinology and Metabolism 84 3293-3300.
65. Jakobs TC, Mentrup B, Schmutzler C, Dreher I & Kohrle J 2002 Proinflammatory cytokines inhibit the expression and function of human type I 5′-deiodinase in HepG2 hepatocarcinoma cells. European Journal of Endocrinology 146 559-566.
66. Jirasakuldech B, Schussler GC, Yap MG, Drew H, Josephson A & Michl J 2000 A characteristic serpin cleavage product of thyroxine-binding globulin appears in sepsis sera. Journal of Clinical Endocrinology and Metabolism 85 3996-3999.
67. Kwakkel J, Wiersinga WM & Boelen A 2007 Interleukin-1beta modulates endogenous thyroid hormone receptor alpha gene transcription in liver cells. Journal of Endocrinology 194 257-265.
68. Kwakkel J, Chassande O, van Beeren HC, Wiersinga WM & Boelen A 2008 Lacking thyroid hormone receptor beta gene does not influence alterations in peripheral thyroid hormone metabolism during acute illness. Journal of Endocrinology 197 151-158.
69. Kwakkel J, van Beeren H, Ackermans M, Platvoet-Ter Schiphorst M, Fliers E, Wiersinga W& Boelen A 2009 Skeletal muscle deiodinase type 2 regulation during illness in mice. Journal of Endocrinology 203 263-270.
70. Larsen PR 2009 Type 2 iodothyronine deiodinase in human skeletal muscle: new insights into its physiological role and regulation. Journal of Clinical Endocrinology and Metabolism 94 1893-1895.
71. Lechan RM 2008 The dilemma of the nonthyroidal illness syndrome. Acta Biomedica 79 165-171.
72. Lechan RM & Fekete C 2004 Feedback regulation of thyrotropin- releasing hormone (TRH): mechanisms for the non-thyroidal illness syndrome. Journal of Endocrinological Investigation 27 105-119.
73. Lechan RM & Fekete C 2005 Role of thyroid hormone deiodination in the hypothalamus. Thyroid 15 883-897.
74. LoPresti JS, Eigen A, Kaptein E, Anderson KP, Spencer CA & Nicoloff JT 1989 Alterations in 3,3′5′-triiodothyronine metabolism in response to propylthiouracil, dexamethasone, and thyroxine administration in man. Journal of Clinical Investigation 84 1650-1656.
75. Maehira F, Luyo GA, Miyagi I, Oshiro M, Yamane N, Kuba M & Nakazato Y 2002 Alterations of serum selenium concentrations in the acute phase of pathological conditions. Clinica Chimica Acta 316 137-146.
76. 3 in euthyroid humans. Journal of Clinical Investigation 115 2524-2533.
77. Mebis L, Langouche L, Visser TJ & Van den Berghe G 2007 The type II iodothyronine deiodinase is up-regulated in skeletalmuscle during prolonged critical illness. Journal of Clinical Endocrinology and Metabolism 92 3330-3333.
78. Mebis L, Paletta D, Debaveye Y, Ellger B, Langouche L, D'Hoore A, Darras VM, Visser TJ & Van den Berghe G 2009a Expression of thyroid hormone transporters during critical illness. European Journal of Endocrinology 161 243-250.
79. Mebis L, Debaveye Y, Ellger B, Derde S, Ververs EJ, Langouche L, Darras VM, Fliers E, Visser TJ & Van den Berghe G 2009b Changes in the central component of the hypothalamus-pituitary-thyroid axis in a rabbit model of prolonged critical illness. Critical Care 13 R147.
80. Mendel CM, Laughton CW, McMahon FA & Cavalieri RR 1991 Inability to detect an inhibitor of thyroxine-serum protein binding in sera from patients with nonthyroid illness. Metabolism 40 491-502.
81. Oetting A & Yen PM 2007 New insights into thyroid hormone action. Best Practice & Research. Clinical Endocrinology & Metabolism 21 193-208.
82. O'Mara BA, Dittrich W, Lauterio TJ & St Germain DL 1993 Pretranslational regulation of type I 50-deiodinase by thyroid hormones and in fasted and diabetic rats. Endocrinology 133 1715-1723.
83. 3 are prognostic markers in critically ill patients and are associated with postmortem tissue deiodinase activities. Journal of Clinical Endocrinology and Metabolism 90 4559-4565.
84. Pilo A, Iervasi G, Vitek F, Ferdeghini M, Cazzuola F & Bianchi R 1990 Thyroidal and peripheral production of 3,5,3′-triiodothyronine in humans by multicompartmental analysis. American Journal of Physiology 258 E715-E726.
85. 3 syndrome in psychiatric depression. Journal of Endocrinological Investigation 29 568-572.
86. Prummel MF, Brokken LJ & Wiersinga WM 2004 Ultra short-loop feedback control of thyrotropin secretion. Thyroid 14 825-829.
87. Ray DC, Macduff A, Drummond GB, Wilkinson E, Adams B & Beckett GJ 2002 Endocrine measurements in survivors and non-survivors from critical illness. Intensive Care Medicine 28 1301-1308.
88. Reilly CP & Wellby ML 1983 Slow thyroxine binding globulin in the pathogenesis of increased dialysable fraction of thyroxine in nonthyroidal illnesses. Journal of Clinical Endocrinology and Metabolism 57 15-18.
89. Renko K, Hofmann PJ, Stoedter M, Hollenbach B, Behrends T, Kohrle J, Schweizer U & Schomburg L 2009 Down-regulation of the hepatic selenoprotein biosynthesis machinery impairs selenium metabolism during the acute phase response in mice. FASEB Journal 23 1758-1765.
90. Rodriguez-Perez A, Palos-Paz F, Kaptein E, Visser TJ, Dominguez-Gerpe L, Alvarez-Escudero J & Lado-Abeal J 2008 Identification of molecular mechanisms related to nonthyroidal illness syndrome in skeletal muscle and adipose tissue from patients with septic shock. Clinical Endocrinology 68 821-827.
91. Roepke TK, King EC, Reyna-Neyra A, Paroder M, Purtell K, Koba W, Fine E, Lerner DJ, Carrasco N & Abbott GW 2009 Kcne2 deletion uncovers its crucial role in thyroid hormone biosynthesis. Nature Medicine 15 1186-1194.
92. Sabeen S, Chou C & Holroyd S 2009 Abnormal thyroid stimulating hormone (TSH) in psychiatric long-term care patients. Archives of Gerontology and Geriatrics DOI: 10.1016/j.archger.2009.06.002.
93. Saberi M, Sterling FH & Utiger RD 1975 Reduction in extrathyroidal triiodothyronine production by propylthiouracil in man. Journal of Clinical Investigation 55 218-223.
94. Sammalkorpi K, Valtonen V, Alfthan G, Aro A & Huttunen J 1988 Serum selenium in acute infections. Infection 16 222-224.
95. Sergeyev V, Broberger C & Hokfelt T 2001 Effect of LPS administration on the expression of POMC, NPY, galanin, CARTand MCH mRNAs in the rat hypothalamus. Brain Research. Molecular Brain Research 90 93-100.
96. Spencer CA 1988 Clinical utility and cost-effectiveness of sensitive thyrotropin assays in ambulatory and hospitalized patients. Mayo Clinic Proceedings 63 1214-1222.
97. Spencer C, Eigen A, Shen D, Duda M, Qualls S, Weiss S & Nicoloff J 1987 Specificity of sensitive assays of thyrotropin (TSH) used to screen for thyroid disease in hospitalized patients. Clinical Chemistry 33 1391-1396.
98. St Germain DL, Galton VA & Hernandez A 2009 Minireview: defining the roles of the iodothyronine deiodinases: current concepts and challenges. Endocrinology 150 1097-1107.
99. Stockigt JR 1996 Guidelines for diagnosis and monitoring of thyroid disease: nonthyroidal illness. Clinical Chemistry 42 188-192.
100. Toyoda N, Berry MJ, Harney JW & Larsen PR 1995 Topological analysis of the integral membrane protein, type 1 iodothyronine deiodinase (D1). Journal of Biological Chemistry 270 12310-12318.
101. Trajkovic M, Visser TJ, Mittag J, Horn S, Lukas J, Darras VM, Raivich G, Bauer K & Heuer H 2007 Abnormal thyroid hormone metabolism in mice lacking the monocarboxylate transporter 8. Journal of Clinical Investigation 117 627-635.
102. Van den Berghe G, de Zegher F, Baxter RC, Veldhuis JD,Wouters P, Schetz M, Verwaest C, Van der Vorst E, Lauwers P, Bouillon R et al. 1998 Neuroendocrinology of prolonged critical illness: effects of exogenous thyrotropinreleasing hormone and its combination with growth hormone secretagogues. Journal of Clinical Endocrinology and Metabolism 83 309-319.
103. Van den Berghe G,Wouters P,Weekers F, Mohan S, Baxter RC, Veldhuis JD, Bowers CY & Bouillon R 1999 Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone-releasing peptide and thyrotropin-releasing hormone in patients with protracted critical illness. Journal of Clinical Endocrinology and Metabolism 84 1311-1323.
104. Van den Berghe G, Baxter RC, Weekers F, Wouters P, Bowers CY, Iranmanesh A, Veldhuis JD & Bouillon R 2002 The combined administration of GH-releasing peptide-2 (GHRP-2), TRH and GnRH to men with prolonged critical illness evokes superior endocrine and metabolic effects compared to treatment with GHRP-2 alone. Clinical Endocrinology 56 655-669.
105. Visser TJ 2007 Thyroid hormone transporters. Hormone Research 68 (Suppl 5) 28-30.
106. Visser WE, Friesema EC, Jansen J & Visser TJ 2008 Thyroid hormone transport in and out of cells. Trends in Endocrinology and Metabolism 19 50-56.
107. Wade S, Bleiberg-Daniel F & Le Moullac B 1988 Rat transthyretin: effects of acute short-term food deprivation and refeeding on serum and cerebrospinal fluid concentration and on hepatic mRNA level. Journal of Nutrition 118 199-205.
108. Williams GR, Franklyn JA, Neuberger JM & Sheppard MC 1989 Thyroid hormone receptor expression in the "sick euthyroid" syndrome. Lancet 2 1477-1481.
109. 3 and nuclear receptor coactivators as a model of the sick euthyroid syndrome. Journal of Biological Chemistry 275 38296-38301.
110. Yu J&Koenig RJ 2006 Induction of type 1 iodothyronine deiodinase to prevent the nonthyroidal illness syndrome in mice. Endocrinology 147 3580-3585.
111. Zeold A, Pormuller L, Dentice M, Harney JW, Curcio-Morelli C, Tente SM, Bianco AC & Gereben B 2006a Metabolic instability of type 2 deiodinase is transferable to stable proteins independently of subcellular localization. Journal of Biological Chemistry 281 31538-31543.
112. Zeold A, Doleschall M, Haffner MC, Capelo LP, Menyhert J, Liposits Z, da Silva WS, Bianco AC, Kacskovics I, Fekete C et al. 2006b Characterization of the nuclear factor-kappa B responsiveness of the human dio2 gene. Endocrinology 147 4419-4429.